Search In this Thesis
   Search In this Thesis  
العنوان
Penetrabilty and concentrations of spiramycin antbiotic in management of juvenile periodontits LJP patients /
المؤلف
Ashour, Hisham Mohamed.
هيئة الاعداد
باحث / Hisham Mohamed Ashour
مشرف / Laila M. A. Gadalla
مشرف / Wael Abbas El Nagar
مشرف / Eatimad A. Shoriba
الموضوع
Papillon Lefevre syndrome. Periodontium - Diseases. Porphyromonas gingivalis infections. Periodontium - Infections.
تاريخ النشر
1995.
عدد الصفحات
59 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
Oral Surgery
تاريخ الإجازة
1/1/1995
مكان الإجازة
جامعة المنصورة - كلية طب الأسنان - Oral Medicine Department
الفهرس
Only 14 pages are availabe for public view

from 72

from 72

Abstract

This study was done on twenty patients suffering from localized juvenile periodontitis .
Five patients were served as control and treated by mechanical cridements only.
The other fifteen patients treated by mechanical :IrrCCeSSeS and antibiotics, Five patients received spiramycin (3.000.000 Ip I : y / 15 days) , five patients received spiramycin (3.000.000 lp I daily / 15 ads) & metronidazole (400 mg / daily I 15 days) and five received racycline (1 gm Idaily I 15 days.
The concentrations of these antibiotics in serum saliva and gingival evicular fluid was measured at base line, after seven days and after teen days.
Clinical paramaters (plaque index , gingival index, pocket depth and ttachement level ) were recorded before and after treatment.
Results showed that combination of spiramycin & metronidazole indicated
-igh concentration comparied to spiramycin alone in the examined area serum, saliva & gingival crevicular fluid The highest concentration in gingival crevicular fluid was in tetracycline group, (5.9 pg/mI after seven days), concentration after fifteen days was the same level.
Serum level at the same time was 2.2 pg/mI at seven days and 2.9 pg/mI after fifteen days.
Spiramycin group (group II) and tetracycline group (group IV) improved gnificantly the gingival, plaque indices and pocket depth.
Patients treated by combination of spiramycin and metronidazole (group II), showed the best clinical results among other groups.